Position in DGX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$5,822,266
+$1,012,917 QoQ
Shares Held
27,470
+11.9% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#225
of 1,090 holders
Holding Since
Dec 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NUANCE INVESTMENTS, LLC holds $95,158,857 across 6 Diagnostics & Research names. DGX ranks #3 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QGEN |
Qiagen N.V.
|
1,595,726 | $62,392,886 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
35,664 | $17,880,503 | |
| 3 | DGX |
Quest Diagnostics Inc
This page
|
27,470 | $5,822,266 | |
| 4 | WAT |
Waters Corp /De/
|
10,762 | $4,036,180 | |
| 5 | DHR |
Danaher Corp /De/
|
17,162 | $3,269,017 | |
| 6 | A |
Agilent Technologies, Inc.
|
13,235 | $1,758,005 |
All Filings in DGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,822,266 | 27,470 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $4,809,349 | 24,540 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $9,640,632 | 55,556 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $5,756,850 | 30,207 | Shares | Sole | 2025-11-06 | |
| 2024-03-31 | $90,732,567 | 681,636 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $83,070,493 | 602,484 | Shares | Sole | 2024-02-07 | |
| No filing history on record for this holder in this stock. | ||||||